CSBIO(SZ:300255) Zhong Guo Jing Ji Wang·2025-11-23 06:52Core Viewpoint - Changshan Pharmaceutical (300255.SZ) announced that its controlling shareholder, Gao Shuhua, plans to transfer 46 million shares, representing 5.0051% of the total share capital, to Chongqing Yuansu Private Securities Investment Fund Management Co., Ltd. This transfer reflects confidence in the company's future development and investment value [1][2]. Group 1 - The controlling shareholder Gao Shuhua holds 280,644,728 shares, accounting for 30.54% of the total share capital [1]. - The transfer price for the shares is set at RMB 46.25 per share, totaling RMB 212,750 million [2]. - After the transfer, the Element Fund will hold 46 million shares, becoming a shareholder with over 5% ownership [1][2]. Group 2 - The transfer price of RMB 46.25 per share represents a fourfold increase compared to the previous transfer price of RMB 9.20 per share in February 2024 [4]. - Gao Shuhua and the company's chairman, Gao Xiaodong, are considered acting in concert due to their father-son relationship [2]. - The transfer is subject to compliance review by the Shenzhen Stock Exchange before the transfer can be processed by the China Securities Depository and Clearing Corporation [1].